Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106


Molecular Features, Markers, Drug Targets, and Prospective Targeted Therapeutics in Cardiac Myxoma

Volume:9   Issue:6
Pp: 705-716
Debmalya Barh, Anil Kumar, Suvro Chatterjee and Triantafillos Liloglou
DOI: 10.2174/156800909789271549

Order Reprints Order Eprints

Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma

Volume:9   Issue:6
Pp: 738-747
H. Huynh, V. C. Ngo, S. P. Choo, D. Poon, H. N. Koong, C. H. Thng, H. C. Toh, L. Zheng, L. C. Ong, Y. Jin, I. C. Song, A. P.C. Chang, H. S. Ong, A. Y.F. Chung, P. K.H. Chow and K. C. Soo
DOI: 10.2174/156800909789271530

Order Reprints Order Eprints

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

Volume:9   Issue:6
Pp: 748-760
J. van der Veeken, S. Oliveira, R. M. Schiffelers, G. Storm, P.M.P. van Bergen en Henegouwen and R. C. Roovers
DOI: 10.2174/156800909789271495

Order Reprints Order Eprints